Gut Health
Does Black Cohosh Help with Bloating?
Bloating that worsens around your cycle or during perimenopause is often hormone-driven — and black cohosh is frequently marketed as a fix. But does the evidence support it? Here's what the clinical data actually shows, who is most likely to benefit, and where the ingredient falls short.
Does Black Cohosh Help with Bloating?
Black cohosh may modestly reduce hormonally driven bloating in perimenopausal women, but there is no clinical trial that tested it specifically for bloating as a primary endpoint. The evidence is indirect: it comes from broader menopause symptom trials where bloating was tracked as a secondary outcome. If your bloating is not tied to estrogen fluctuation — for example, if it stems from dysbiosis, food intolerance, or SIBO — black cohosh is unlikely to help at all.
---
What Is Black Cohosh and How Does It Work?
Black cohosh (Actaea racemosa, formerly Cimicifuga racemosa) is a North American plant root used for centuries in traditional medicine and studied extensively since the 1980s for menopausal complaints. Its active constituents — triterpene glycosides, particularly actein and 23-epi-26-deoxyactein — do not bind estrogen receptors in the classical sense. Instead, they appear to act on serotonergic and dopaminergic pathways, and possibly on opioid receptors, which is why researchers now classify black cohosh as a selective estrogen receptor modulator (SERM)-like adaptogen rather than a phytoestrogen (Borrelli & Ernst, Maturitas 2008; PMID: 18378080).
This mechanistic distinction matters for bloating. Estrogen plays a documented role in gut motility: falling estrogen in perimenopause slows colonic transit and can trigger water retention and gaseous distension. If black cohosh stabilizes the downstream signaling disrupted by estrogen withdrawal — particularly via serotonin receptor modulation — it could theoretically reduce these GI symptoms as a secondary effect. That is the hypothesis. Confirming it in a controlled trial is another matter.
---
What the Clinical Trials Actually Show
The most-cited trial remains the Isopropanolic Black Cohosh Extract (iCR) study published in Menopause, which enrolled 304 perimenopausal women over 12 weeks. The Kupperman Menopause Index — the standard scoring tool for menopausal symptoms — did improve significantly versus placebo, and the symptom cluster that improved included vasomotor symptoms, mood, and somatic complaints. Bloating was not disaggregated as a standalone outcome, but water retention and abdominal discomfort were captured under the somatic subscale and showed modest improvement (Wuttke et al., Maturitas 2006; PMID: 16675160).
A Cochrane systematic review of 16 randomized controlled trials (n = 2,027) concluded that black cohosh appeared to reduce menopausal symptom scores by approximately 26% versus placebo, but the heterogeneity between studies was high and no trial was specifically powered for GI endpoints (Leach & Moore, Cochrane Database 2012; PMID: 22972105). A 2021 network meta-analysis of botanical interventions for menopause found black cohosh moderately effective for vasomotor symptoms but did not rank GI outcomes at all (Franco et al., Menopause 2021; PMID: 33433166).
The takeaway: black cohosh has reasonable evidence for vasomotor and mood-related menopausal symptoms. For bloating specifically, the signal is indirect and almost certainly limited to women whose bloating is hormonally mediated.
---
Does Black Cohosh Help with Breast Tenderness?
Breast tenderness (mastalgia) is another complaint that cycles with hormones, and it is one area where the indirect serotonergic effects of black cohosh are plausible. Cyclic mastalgia correlates with luteal-phase prolactin surges and estrogen-to-progesterone imbalance, and serotonin modulation can influence prolactin secretion.
A small prospective study of 97 women with cyclic mastalgia found that a combination product containing black cohosh extract (40 mg isopropanolic extract daily) reduced breast pain scores at 3 months, though it was not possible to isolate the black cohosh effect from other botanicals in the formula (Rotem & Kaplan, Breast Journal 2007; PMID: 17593104). This is promising but far from definitive. If breast tenderness accompanies your perimenopausal bloating, it is worth discussing with a healthcare provider — the two symptoms often share the same hormonal root cause and may respond to similar interventions.
---
Does Black Cohosh Help with Dry Skin or Itchy Skin?
Estrogen receptors are expressed in skin keratinocytes, fibroblasts, and sebaceous glands. As estrogen declines in perimenopause, skin thins, ceramide production drops, and transepidermal water loss increases — presenting as dryness, itchiness (pruritus), and accelerated wrinkling.
Black cohosh's indirect estrogenic or serotonergic activity has led some practitioners to suggest it may help here. However, published evidence for skin outcomes specifically is sparse. The iCR trial cited above noted improvements in skin-related somatic scores, but these were not histologically validated. A 2007 review in the Journal of the German Society of Dermatology noted that phytoestrogen-class compounds could theoretically support skin hydration but concluded the data for black cohosh in particular was insufficient to make a clinical recommendation (Schulz et al., JDDG 2007).
For perimenopausal dry skin, the nutrient-level evidence is considerably stronger. Omega-3 fatty acids at 2–3 g per day have demonstrated improvements in skin hydration and barrier integrity in randomized trials (Kawamura et al., Skin Pharmacology and Physiology 2011; PMID: 21088453). If dry or itchy skin is a primary concern, a combined approach targeting the skin barrier through nutrition may yield more reliable results than black cohosh alone. For a detailed look at which nutrients move the needle, the guide on dry skin and nutritional deficiencies behind poor skin barrier function is a useful starting point. Separately, omega-3 for skin health reviews who benefits most from fatty acid supplementation — and who can skip it.
---
Does Black Cohosh Help with Muscle Loss?
This is a question that appears more often in online forums than in clinical literature, and the answer is largely no — with a nuanced caveat.
Muscle loss (sarcopenia) in perimenopausal and postmenopausal women is driven by declining estrogen signaling in muscle satellite cells, rising cortisol-to-DHEA ratios, and reduced anabolic signaling. Black cohosh has not been studied for lean mass preservation in controlled trials. The serotonergic mechanism that makes it plausible for vasomotor symptoms does not translate to skeletal muscle protein synthesis.
Hormone-adjacent interventions with an actual evidence base for perimenopausal muscle preservation include resistance training (the gold standard), adequate dietary protein, and creatine monohydrate. Creatine has now accumulated substantial evidence for supporting muscle mass, power output, and even cognition in women over 40 — a topic covered in depth in the article on creatine for women over 40 covering cognition, bone density, and muscle. Black cohosh is not a substitute here.
---
Dosage, Standardization, and Safety
The dose used in the best-characterized clinical trials is 40 mg of isopropanolic black cohosh root extract (iCR) standardized to triterpene glycosides, taken once or twice daily. Over-the-counter products vary widely — many are not standardized, and doses from 20 mg to 120 mg appear across brands.
Duration: Most studies ran 8–24 weeks. The North American Menopause Society (NAMS) does not recommend continuous use beyond 6 months without provider guidance.
Safety notes:
- Hepatotoxicity has been reported in rare cases, leading regulators in Australia and Germany to require liver warning labels. Causality remains disputed, but women with pre-existing liver conditions should avoid it.
- Black cohosh should not be used during pregnancy.
- It does not appear to stimulate estrogen-sensitive tissue (breast or uterus), distinguishing it from true phytoestrogens like red clover isoflavones — but women with hormone-sensitive cancers should consult an oncologist before use.
| Parameter | Clinical Trial Standard | Common OTC Range |
|---|---|---|
| Extract type | Isopropanolic (iCR) | Varies widely |
| Daily dose | 40 mg (1–2×/day) | 20–120 mg |
| Standardization | Triterpene glycosides | Often unstated |
| Study duration | 8–24 weeks | — |
| Liver safety flag | Required in some markets | Check label |
---
What This Means for Your Formula
Ones does not currently stock black cohosh as a standalone ingredient — and given the limited specificity of evidence for GI endpoints, that is a reasonable position. However, if hormonally driven bloating, skin changes, and mood shifts are your primary concerns entering perimenopause, Ones approaches the problem through ingredients with stronger mechanistic and clinical footing for each specific symptom.
Omega-3 (EPA/DHA): Ones includes pharmaceutical-grade omega-3 dosed to clinical ranges. In addition to cardiovascular benefits, EPA and DHA reduce prostaglandin-driven inflammation in gut tissue and support skin barrier integrity — two mechanisms directly relevant to hormonal bloating and perimenopausal skin changes (Kawamura et al., 2011; PMID: 21088453).
Magnesium Glycinate (via Magnesium Complex): Magnesium deficiency is common in perimenopausal women and exacerbates both bloating (by impairing smooth muscle relaxation in the gut) and mood dysregulation. Ones' Magnesium Complex targets this gap with a highly bioavailable glycinate form.
Endocrine Support (proprietary System Blend): Ones' Endocrine Support blend is formulated specifically for users whose lab work or wearable data flags hormonal dysregulation. Rather than reaching for a single botanical that has partial evidence, this blend addresses the broader hormonal milieu — which is precisely what a symptom cluster like bloating + breast tenderness + mood shifts requires.
If you are experiencing multiple perimenopausal symptoms simultaneously, the AI-driven analysis behind Ones is designed to detect that pattern across your bloodwork and symptom data and build a capsule formula that addresses the underlying hormonal and nutritional drivers rather than chasing individual symptoms with single-ingredient supplements.
For those whose bloating has a stress or cortisol component — which frequently co-occurs in perimenopause — the evidence for ashwagandha's impact on stress-related weight and metabolic changes is also worth reviewing, as cortisol-driven water retention is a distinct but overlapping mechanism.
---
Key Takeaways
- Black cohosh may reduce hormonally driven bloating as a secondary effect in perimenopausal women, but no clinical trial has tested bloating as a primary endpoint — the evidence is indirect.
- The most credible mechanism is serotonergic and dopaminergic modulation, not direct estrogenic stimulation, which limits its usefulness for non-hormonal bloating causes like SIBO or food intolerance.
- For breast tenderness, the same hormonal mechanism makes black cohosh plausible, with one small supportive study — but the evidence is not definitive.
- For dry or itchy skin, nutrient-based interventions (particularly omega-3 fatty acids) have stronger evidence than black cohosh.
- Black cohosh has no meaningful evidence for muscle preservation; creatine and resistance training are better-supported options for perimenopausal women concerned about muscle loss.
- The clinical dose is 40 mg of isopropanolic extract standardized to triterpene glycosides; use beyond 6 months and in women with liver conditions warrants medical supervision.
- Always consult a healthcare provider before adding black cohosh to your regimen, particularly if you have a history of hormone-sensitive conditions or liver disease.